Sponsor or institution

Clinical trials and research at Microbiotix, INC

• 9NIH research projects

NIH-funded research (9)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Novel Benzyl-Piperidine antifungals to fight hard-to-treat mucormycosis

  A new drug candidate series called Benzyl-Piperidines is being developed to treat invasive mucormycosis, a deadly fungal infection often affecting people with weakened immune systems.

  NIH research Microbiotix, INC · Worcester, United States · NIH-11419678

• Well-tolerated new drugs to fight drug-resistant CMV in transplant patients

  A new class of CMV drugs that are easier to tolerate is being developed to prevent or treat CMV infections in people who have had solid organ or bone marrow transplants.

  NIH research Microbiotix, INC · Worcester, United States · NIH-11387896

• Discovery of small-molecule inhibitors to stop bunyavirus endonuclease

  A small-molecule approach is being developed to block a key enzyme of bunyaviruses like Rift Valley fever, with the goal of preventing or treating infections in people and animals.

  NIH research Microbiotix, INC · Worcester, United States · NIH-11332712

• Filociclovir eye drops for adenoviral conjunctivitis and epidemic keratoconjunctivitis

  This project is developing an antiviral eye drop, filociclovir, to treat adenovirus eye infections like conjunctivitis and the more severe epidemic keratoconjunctivitis.

  NIH research Microbiotix, INC · Worcester, United States · NIH-11248388

• Finding new treatments for a dangerous mosquito-borne virus.

  This study is working on new antiviral medicines to help fight the Rift Valley Fever Virus, which can make people very sick, by creating tiny molecules that stop the virus from spreading, since there are no approved treatments or vaccines for it yet.

  NIH research Microbiotix, INC · Worcester, United States · NIH-11184904

• Creating new treatments for antibiotic-resistant bacteria

  This study is working on creating new treatments to help fight infections caused by tough bacteria that don't respond to regular antibiotics, so patients can have better options for getting better.

  NIH research Microbiotix, INC · Worcester, United States · NIH-11140253

• Developing new treatments for burn wound infections caused by antibiotic-resistant bacteria.

  This study is looking at a new treatment to help fight infections from a tough bacteria called Pseudomonas aeruginosa that can affect burn wounds, and if successful, it could offer better care for patients dealing with these kinds of infections.

  NIH research Microbiotix, INC · Worcester, United States · NIH-11074661

• Developing a new treatment for adenoviral eye infections

  This study is testing a new eye drop treatment for adenoviral conjunctivitis, which is an eye infection that currently has no good options for help, and it's aimed at people who suffer from this condition.

  NIH research Microbiotix, INC · Worcester, United States · NIH-11037317

• Creating new antiviral treatments for deadly filoviruses like Ebola

  This study is working on new treatments for serious viruses that cause severe fevers by creating special antibodies that can fight different strains of the virus, and it aims to find better ways to stop the virus from entering human cells before testing these treatments in animals.

  NIH research Microbiotix, INC · Worcester, United States · NIH-10911352

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →